When a Deal Falls Apart, Governance Takes Centre Stage

‍

When Allied Gold and Zijin Gold announced that their proposed C$5.5-billion acquisition would not proceed, the market’s verdict was swift.

With Chinese regulatory approvals unlikely to arrive before the outside date, the deal collapsed, Zijin settled for a 9.2% strategic stake instead, and Allied’s shares fell 18.6%. Investors who had endorsed a C$44-per-share offer woke up holding a company trading materially below it.

The collapse may have been beyond either board's control. But preparing for that possibility is not. In today's geopolitical environment, board preparedness has become central to deal certainty.

Canada has seen this story before. In 2008, the proposed $52-billion privatization of Bell Canada, the country's largest buyout at the time collapsed as the global financial crisis froze credit markets. Two years later, BHP Billiton's hostile bid for PotashCorp was blocked after the federal government determined it was not of "net benefit" to Canada. Different transactions, different outcomes but the same lesson. Landmark deals can unravel for reasons far beyond valuation or shareholder support.

For years, deal success was measured by securing an attractive premium and shareholder approval. Those benchmarks are no longer enough. Regulatory and geopolitical forces increasingly determine whether transactions close. Deal certainty has become a governance issue deserving the same board attention as valuation, financing and execution.

Every transaction is a negotiation over risk as much as value. When deals close, the provisions allocating that risk attract little attention. When they fail, those provisions become the entire conversation. Shareholders who approved a transaction will inevitably revisit the assumptions behind the board’s recommendation.

Were closing risks properly assessed? Were shareholders adequately protected if the deal died?

These questions do not imply fault. They reflect the standard of oversight investors now expect.

What should boards overseeing transformational transactions do?

First, stress-test the regulatory path before signing, not after. Boards should demand independent analysis of approval timelines in every relevant jurisdiction, including realistic worst-case scenarios, and set outside dates that reflect those realities rather than deal momentum.

Second, price geopolitical risk into the contract. Reverse break fees and extension mechanisms should be calibrated to the actual regulatory risk profile of the transaction. If home-country approvals are the gating risk, the counterparty should bear that risk.

Third, plan for failure on day one. Too many boards approve transactions with no standalone contingency plan. The day a deal is announced, the board should already know how it will communicate, operate and create value if the deal never closes.

Investors forgive failed transactions. They are far less forgiving of boards caught flat-footed by them.

Fourth, consider the aftermath. A failed acquirer that remains a significant shareholder, as Zijin has, can wield meaningful influence without paying a control premium. Boards must be prepared for the governance implications.

Boards must also be prepared to manage that relationship transparently and on behalf of all shareholders.

Finally, communicate. A failed transaction is a governance inflection point that invites renewed scrutiny of strategic judgment. Boards that emerge with credibility intact are those that clearly explain why the deal failed, what was learned and how they will create value going forward.

None of this diminishes the quality of any particular company’s assets or the rationale that attracted a premium offer in the first place. But the lesson of this moment extends well beyond one transaction. In an era when geopolitics can unwind even well-structured deals, negotiating value is only half a board’s job.

The other half is negotiating certainty.